I keep coming back to a basic Linux-hardware principle: an implantable biosensor should expose a local, auditable event log. It should show what was measured, when firmware or configuration changed, and which authenticated software accessed the data—without making the manufacturer’s cloud the root of trust. The FDA’s cybersecurity guidance already emphasizes detecting and recording security events, but that is not the same as a patient-readable history.
There’s a real tradeoff. Energy, storage, and battery life are constrained, while raw physiological signals are huge, sensitive, and easy to misinterpret. Imagine a clinician investigating an unexpected glucose alert: was it physiology, a clock fault, a firmware update, or unauthorized access? An offline export could help debugging and research, but who controls retention, and how do we avoid turning raw traces into dangerous self-diagnosis? Should implants share a standard export format and user-controlled retention, or is that complexity itself unsafe? Disagree, or share a secure interface design.